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Summary: Short, hairpin RNA (shRNA) directed against
bone morphogenetic protein 4 (Bmp-4) was delivered to
early postimplantation staged mouse embryos via tail
vein injection of pregnant dams. As early as 24 h postin-
jection, embryos expressed a DsRed marker and later
exhibited defects of neural fold elevation and closure
and of cardiac morphogenesis. Immunohistochemical
analysis of sectioned embryos indicated that Bmp-4 pro-
tein was depleted and gene expression analysis indi-
cated there was a reduction in Bmp-4 mRNA and an
upregulation of the Bmp-4 antagonists, noggin and
chordin, in embryos exposed to the shRNA, but not in
control embryos. There was no change in the expression
of Gata4, brachyury, or claudin6 in RNAi exposed em-
bryos, indicating that RNA silencing was specific to
Bmp-4 rather than producing widespread gene inhibi-
tion. Delivery of shRNA to embryos has the potential to
specifically knockdown the expression of developmen-
tally essential genes and to rescue gene mutations, sig-
nificantly decreasing the time required to analyze the
function(s) of individual genes in development. genesis
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Gene targeting in the mouse embryo has produced tre-
mendous insights into gene function during develop-
ment (Doetschmann et al., 1987; Thomas and Capecchi,
1987). Although gene deletion is considered to be the
gold standard, generation of targeted mutant mice is a
tedious process and problematic if the targeted gene
produces an embryonic lethal phenotype. Other ap-
proaches such as using morpholino antisense oligonu-
cleotides have also been developed to disrupt gene ex-
pression in embryos, but have not been widely
employed because of problems with toxicity, nonspe-
cific effects, and the short life of the morpholino (Siddall
et al., 2002). Over the last few years, there have been
tremendous advances in sequence-specific gene silenc-
ing using RNA interference techniques (Paddison and
Hannon, 2002). The phenomenon was identified in Cae-
norhabditis elegans, where it was noted that the control
RNA (sense RNA) also downregulated gene expression.
It was initially thought that this was an aberrant cellular
event, but it is now clear that this process is an innate
method employed by many organisms to control gene
expression. In addition, RNA interference is now recog-
nized as a powerful tool to produce gene silencing.
When introduced into cells, small interfering RNAs
(siRNA), or RNAs expressed as short hairpins (shRNA),
efficiently target and cause degradation of the cognate
RNAs (Paddison and Hannon, 2002).
Posttranscriptional gene silencing by RNAi has been
employed extensively in C. elegans (Fire et al., 1998)
and more recently in mammalian cells (Elbashir et al.,
2001; Brummelkamp et al., 2002; Yang et al., 2001,
2002). siRNAs have been expressed in mouse embryos
by electroporation or injection of preimplantation staged
embryos (Grabarek et al., 2002; Wianny and Zernicka-
Goetz, 2002), and in postimplantation embryos via exo-
utero surgery and regional electroporation (Calegari et
al., 2002). Transgenic expression of siRNA has also re-
cently been achieved by electroporation of ES cells fol-
lowed by chimera formation (Carmell et al., 2003; Ru-
binson et al., 2003), or following tetrapoloid aggregation
(Kunath et al., 2003), which produced embryos that
expressed shRNA to Rasa 1 and phenocopied the Rasa1
null mouse. Others have injected fertilized eggs with
shRNA plasmids (Hasuwa et al., 2002) or transduced
two-cell embryos with lentiviral vectors expressing
shRNAs (Tiscornia et al., 2003) and observed stable,
heritable gene knockdown. RNA interference has the
advantages that individual genes or combinations can be
targeted, multiple regions of the same transcript can be
targeted, and the RNAi can be constitutively expressed
to produce long-term gene suppression. If delivered to
pregnant animals, the length of time required to assess
gene function could be greatly reduced compared with
conventional germ line mutagenesis strategies. Unlike
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gene targeting using siRNA in ES cells, this approach
allows targeting of genes expressed in the trophoblast
and yolk sac—structures that are not normally formed
from ES cells, as well as genes involved in growth and
maintenance of the ES cells themselves. In addition, the
timing of the delivery of the shRNA can be precisely
controlled to target the stage of interest, making it a
powerful approach to study genes whose loss of func-
tion produces early embryonic lethality. Finally, different
levels of RNA silencing (Hemann et al., 2003) produced
by targeting different regions of the transcript may be
effective in generating hypomorphic alleles and in teas-
ing out gene structure/function relationships.
In this investigation, we delivered shRNA targeted to
bone morphogenetic protein 4 (Bmp-4) mRNA (Fig. 1) to
early postimplantation staged mouse embryos using tail
vein injection. Rather than coinjection of a reporter
plasmid with separate siRNAs (Calegari et al., 2002;
Miyagishi and Taira, 2002; Ya et al., 2002), a single
vector was designed in which DsRed was expressed
from the CMV promoter and constitutive expression of
Bmp-4i was controlled by the mouse RNA polymerase III
U6 promoter (Miyagishi and Taira, 2002; Ya et al., 2002).
Unlike high-pressure tail vein injection designed to open
capillaries and deliver an siRNA to adult tissues (Lewis et
al., 2002), we employed low-pressure injection to de-
liver the shRNA, with the goal of examining the effects
of Bmp-4 gene knockdown during early postimplanta-
tion stages of embryonic development.
Embryonic day (E) 6.5 time pregnant mice were in-
jected via the tail vein with either pCS2/Red (control) or
pCS2/Red/Bmp-4i (pBmp4i), and sacrificed after 24 h,
48 h, 72 h, and 8 days (E14.5) postinjection. As early as
24 h postinjection, embryos expressed DsRed (Fig. 2A),
with expression persisting over the next 72 h, extending
to E14.5 (Fig. 2C). Within an individual litter, there was
some variation between embryos in their expression of
the DsRed marker: a majority (64%) of the embryos
examined expressed DsRed with no preference for a
particular day of gestation. Controls expressed DsRed
within all tissues in the embryo (Fig. 2G) and no mor-
phological abnormalities were observed in these em-
bryos. Bmp-4i exposed embryos exhibited a number of
morphological alterations, including defects of neural
tube closure consisting of a failure of neural fold eleva-
tion in the cephalic region (Fig. 2B), rachischisis, a trun-
cated posterior axis, and occasionally a small allantois.
The first branchial arch was often hypoplastic and de-
fects of cardiac looping were also evident. These phe-
notypes appeared to reflect hypomorphic behavior of
the lethal phenotype previously observed in germline-
targeted Bmp-4 null embryos (Fujiwara et al., 2001,
2002; Hebert et al., 2003). It would be of considerable
interest to examine primordial germ cell differentiation
in these embryos since the expression of genes such as
fragilis that are involved in specification of primordial
germ cells also appear to be affected by Bmp-4 expres-
sion levels (Lawson et al., 1999; Saitou et al., 2002).
Interestingly, maternal tissues expressed variable levels
of the DsRed marker, as observed previously (Lewis et
al., 2002). There was constant high expression in liver,
pancreas, spleen, and heart, and variable expression in
skin and striated muscle, while brain never expressed
DsRed.
To determine if Bmp-4 protein expression was af-
fected in the shRNA exposed embryos, immunohisto-
chemical analyses were carried out on sectioned em-
bryos (Fig. 3). Unlike control embryos that expressed
high levels of Bmp-4 in the surface ectoderm (Fig. 3E,F),
there was very little Bmp-4 protein in the shRNA-ex-
posed embryos (Fig. 3A–D). Scattered Bmp-4 immunore-
activity was present in the surface ectoderm of embryos
on E8.5 and E9.5; by E14.5 there was little expression in
the CNS, lung, or epidermal ectoderm. The function of
the Bmp-4 hairpin was also assessed by comparison of
Bmp-4 expression in control (pCSRed) and pBmp-4i em-
bryos using RT-PCR. The expression of Bmp-4 mRNA
was diminished 4–8-fold in embryos that received the
Bmp-4i cassette (Fig. 4, lane 1) compared to pCSRed
control embryos. Importantly, expression of the DsRed
or Bmp-4i cassettes did not affect global transcriptional
regulation as expression of an endoderm marker Gata4
(Fig. 4, lane 6), Brachyury (T), a mesoderm marker (Fig.
4, lane 7), claudin6, an ectoderm marker (Fig. 4, lane 8),
and -actin, a positive control (Fig. 4, lane 9), were
similar in both groups, indicating that the shRNA si-
lenced Bmp-4 specifically rather than producing wide-
spread gene inhibition. Interestingly, mRNA for the
Bmp-4 antagonists, chordin and noggin, was upregulated
in Bmp-4i exposed embryos (4-fold and 12-fold, respec-
tively) (Fig. 4, lanes 2 and 3). Musashi1, a marker of
primitive neuroepithelium, was strikingly upregulated in
the presence of Bmp-4i by 30-fold (Fig. 4, lane 4). Nodal,
a downstream target of Bmp-4 was unexpectedly up-
regulated 3-fold (Fig. 4, lane 5), possibly releasing con-
trol over L- R-asymmetry in the embryo.
These results demonstrate for the first time the sys-
temic delivery and expression of shRNA directed to a
gene critical in the development of postimplantation
mouse embryos. The results phenocopy many of the
characteristics of the Bmp-4 gene targeted embryos and
identify alterations in the expression of target genes.
Although it is not yet known if this approach will be
FIG. 1. Schematic of the predicted hairpin structure containing the
antisense and sense regions that target the Bmp4 gene, and a 9 bp
loop.
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successful later in development after placental develop-
ment is more complete, this potential limitation might
be overcome by early injection of plasmids in which
expression of the RNAi is controlled by an inducible
promoter. The use of RNAi to study gene function in
development has many advantages including: precise
control of gene knockdown at a specific stage of embry-
onic development, the ability to target multiple genes
without complicated breeding regimens, to attempt
gene rescue, and in the long term to treat genetic,
prenatal conditions.
MATERIALS AND METHODS
Construction of cDNA Expression Vectors
A BamHI/XbaI fragment that contained the DsRed cod-
ing region was removed from pDsRed2-1 (ClonTech,
Palo Alto, CA) and ligated into the first MCS of pCS2
(Turner and Weintraub, 1994) to generate pCS2/Red.
The mouse U6 promoter (GenBank X06980) was PCR-
amplified from genomic DNA and cloned into the EcoRI
and BamHI sites in pBS SK (Stratagene, La Jolla, CA) to
yield pSKU6. An RNAi hairpin was designed to target nt
305–323 of the Bmp-4 mRNA (GenBank X56848) and
ligated downstream of the U6 promoter in pSKU6 (Fig.
1). The final vector pCS2/Red/Bmp-4i was constructed
by removing the U6/BMP-4i cDNA from the SK using
NotI and KpnI followed by ligation of this cDNA into the
second MCS of pCS2/Red to yield pCS2/Red/Bmp-4i
(pBmp-4i). Plasmid preparations for injections were pre-
pared with the Qiagen (Chatsworth, CA) Maxi Prep Kit.
Tail Vein Injections
Plasmids (10 g) were diluted in Ringer’s solution and
injected into the tail vein of unanesthetized, time preg-
nant (E6.5; plug day  E0.5) mice (CD-1, Charles River,
Portage, MI) in a volume of 250 l, using a 23 G butterfly
needle and a 1 cc syringe. At least 10 mice were injected
per replicate experiment (n  4 replicates). Over 398
embryos from a total of 32 pregnant females were ex-
FIG. 2. Embryos were isolated on
E7.5 (A), E8.5 (B,D–G), or E14.5
(C) of gestation from pregnant fe-
males injected on gestation E6.5
with Bmp-4i (A–E) or DsRed con-
trol plasmid (F,G). As early as 24 h
postinjection, the DsRed marker
was expressed in E7.5 embryos
(A) and was uniformly distributed
throughout sectioned embryos
examined on E14.5 (C) or on E8.5
(E,G). Embryos exposed to
Bmp-4i exhibited defects of neu-
ral fold elevation and closure (B),
turning and cardiac rotation
(B,D,E), compared with morpho-
logically normal control embryos
(F,G). Asterisks indicates the car-
diac region; arrow in A, the fo-
regut pocket. a  allantois; h 
headfolds; SE  surface ecto-
derm; NE  neuroepithelium;
M  forming myotome; DRG 
dorsal root ganglion; p 
pharynx.
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amined. Mice were sacrificed at 24 h, 48 h, 72 h, and 8
days (E14.5) postinjection. Embryos were removed from
the uterus and membranes and examined using epifluo-
rescence microscopy to determine the extent of DsRed
expression. Embryos were then either processed for
histological analysis, SEM, or RNA extraction. Additional
maternal tissues: spleen, liver, kidney, lung, heart, stri-
ated muscle, skin, and brain were removed 72 h postin-
jection and embedded in OCT. Frozen sections were cut
and examined using epifluorescence to determine the
pattern of expression of the DsRed marker.
Immunohistochemical localization of Bmp-4 protein
was carried on 10- thick frozen sections of embryos.
Sections were fixed briefly, washed, blocked, then ex-
posed to anti-Bmp-4 antibodies (1:50, Santa Cruz Bio-
technology, sc-6896, Santa Cruz, CA) followed by sec-
FIG. 3. Immunohistochemical
localization of Bmp-4 protein in
embryos exposed to pBmp-4i
(A-D), and DsRed control em-
bryos (E,F). Phase contrast mi-
crographs (A,C,E) illustrate the
organization of the surface ecto-
derm (SE) and underlying neuro-
epithelium (NE). The neural folds
are collapsed in this early somite
embryo (E8.5, A,B) obliterating
much of the mesenchyme. There
was no immunoreactivity for
Bmp-4 in the surface ectoderm,
where it is normally expressed;
with slight expression in the mid-
line (arrow) and in the endoderm
surrounding the pharynx (P). By
E9.5 (C,D), the neural folds had
not yet closed in many of the
Bmp-4i-exposed embryos, and
there was only slight scattered
staining of Bmp-4 (arrows) in the
surface ectoderm (SE). Control
embryos exhibited normal neural
tube closure and strong immuno-
reactivity for Bmp-4 in the surface
ectoderm (E,F).
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ondary antibodies conjugated to FITC. Sections were
examined and photographed using epifluorescence mi-
croscopy and digital images imported to PhotoShop
(Adobe Systems, Mountain View, CA) to construct illus-
trations.
RT-PCR Analysis of Gene Expression
RNA was extracted from E8.5 and E9.5 embryos with
Trizol (ILT), DNAsed, and quantified. Approximately
10–12 embryos were recovered per litter and combined
in a single Trizol aliquot for extraction. One control and
two Bmp-4i-exposed litters were examined for each ex-
periment. The RT-PCR was done in triplicate for each
embryo pool. The RNAs (1 g) served as templates in
oligo dT primed reverse transcription (RT) reactions,
then 1/10 of the reaction was used as a template in PCR
with gene-specific primers. The optimal number of PCR
cycles was determined for each primer pair to ensure
amplification in the linear range (Gratsch, 2002). Gen-
eral PCR conditions were 94°/3 min, 94°/30 sec–1 min,
51–60°/1 min, 72°/2 min for 25–35 cycles, and a final
extension of 72/7 min.
PCR primers.
-actin, F-aaccctaaggccaaccgtg, and R-caggattccatacccaa-
gaagg (498 bp, 22 cycles); Bmp-4, F-ctcccaagaatcatggactg
and R-aaagcagagctctcactggt (468 bp, 32 cycles); noggin,
F-cccggtgctgtacgcgtgg and R-gcaggaacacttacactcg (250 bp,
29 cycles); chordin, F-accaacgcagtagagacctccc and R-gggg-
tagcaggaatggtgtg (901 bp, 30 cycles); DsRed, F-tcaccgagt-
tcatgcgcttca and R-cgttgtgggaggtgatgtccagct (593 bp, 30
cycles); Musashi 1, F-ttccaagccacgacctacgc and R-ggagc-
gagagaagagacaaggtctg (638 bp, 30 cycles); nodal, F-atttgc-
cagacagaagccaac and R-tcctccacaatcatgtccttg (312 bp, 29
cycles); Brachyury, F-agaaagaaacgaccacaaagatg and R-att-
tatttatttttcccttgtcc (729 bp, 33 cycles); Claudin 6, F-gatag-
gaactccaagtctcgt and R-tgggacagatgtagaatagca (287 bp, 29
cycles); Gata4, F-ccgagcaggaatttgaagagg and R-gcctgtatgta-
atgcctgcg (469 bp, 35 cycles). The PCR products were
electrophoresed in 1.5% agarose/EtBr gels and photo-
graphed in a UV light box. For semiquantitative analyses,
the gels were scanned, then analyzed using a Lab Works 4.0
(Cybergenetics, Pittsburgh, PA) densitometry program.
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